# Effect of Zinc Supplementation on Hyperhomocysteinemia Compared to Folic Acid in CKD Patient on Hemodialysis

> **NCT06847139** · NA · RECRUITING · sponsor: **Chittagong Medical College** · enrollment: 90 (estimated)

## Conditions studied

- Chronic Kidney Disease Requiring Hemodialysis

## Interventions

- **DRUG:** Zinc Sulfate 50 Mg Tab
- **DRUG:** Folic Acid 5 Mg Oral Tablet

## Key facts

- **NCT ID:** NCT06847139
- **Lead sponsor:** Chittagong Medical College
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2025-07-30
- **Final completion:** 2025-10-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06847139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06847139, "Effect of Zinc Supplementation on Hyperhomocysteinemia Compared to Folic Acid in CKD Patient on Hemodialysis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06847139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*